Issue 8/2013
Content (21 Articles)
Physical activity, physical fitness and the effect of exercise training interventions in lymphoma patients: a systematic review
Nele Vermaete, Pascal Wolter, Gregor Verhoef, Rik Gosselink
Persisting fatigue in Hodgkin lymphoma survivors: a systematic review
Laurien A. Daniëls, Simone Oerlemans, Augustinus D. G. Krol, Lonneke V. van de Poll-Franse, Carien L. Creutzberg
Rituximab, bendamustine, and lenalidomide in patients with aggressive B cell lymphoma not eligible for high-dose chemotherapy or anthracycline-based therapy: phase I results of the SAKK 38/08 trial
F. Hitz, N. Fischer, Th. Pabst, C. Caspar, G. Berthod, K. Eckhardt, S. Berardi Vilei, E. Zucca, U. Mey
DexaBEAM versus ICE salvage regimen prior to autologous transplantation for relapsed or refractory aggressive peripheral T cell lymphoma: a retrospective evaluation of parallel patient cohorts of one center
Jan-Henrik Mikesch, Mareike Kuhlmann, Angela Demant, Utz Krug, Gabriela B. Thoennissen, Eva Schmidt, Torsten Kessler, Christoph Schliemann, Michele Pohlen, Michael Mohr, Georg Evers, Gabriele Köhler, Johannes Wessling, Rolf Mesters, Carsten Müller-Tidow, Wolfgang E. Berdel, Nils H. Thoennissen
High-dose imatinib versus high-dose imatinib in combination with intermediate-dose cytarabine in patients with first chronic phase myeloid leukemia: a randomized phase III trial of the Dutch-Belgian HOVON study group
Noortje Thielen, Bronno van der Holt, Gregor E. G. Verhoef, Rianne A. H. M. Ammerlaan, Pieter Sonneveld, Jeroen J. W. M. Janssen, Wendy Deenik, J. H. Frederik Falkenburg, Marie José Kersten, Harm A. M. Sinnige, Martin Schipperus, Anton Schattenberg, Rien van Marwijk Kooy, Willem M. Smit, Isabel W. T. Chu, Peter J. M. Valk, Gert J. Ossenkoppele, Jan J. Cornelissen
Polymorphisms of the IL-23R gene are associated with primary immune thrombocytopenia but not with the clinical outcome of pulsed high-dose dexamethasone therapy
Yanxia Zhan, Fanli Hua, Lili Ji, Weiguang Wang, Shanhua Zou, Xiaoyun Wang, Feng Li, Yunfeng Cheng
The clinical characteristics and prognostic significance of MN1 gene and MN1-associated microRNA expression in adult patients with de novo acute myeloid leukemia
Lili Xiang, Man Li, Yan Liu, Jiangnong Cen, Zixing Chen, Xiao Zhen, Xiaobao Xie, Xiangshan Cao, Weiying Gu
Impact of NOD2 polymorphisms on infectious complications following chemotherapy in patients with acute myeloid leukaemia
Olaposi Yomade, Bärbel Spies-Weisshart, Anita Glaser, Ulf Schnetzke, Andreas Hochhaus, Sebastian Scholl
Monitoring dendritic cell and cytokine biomarkers during remission prior to relapse in patients with FLT3-ITD acute myeloid leukemia
Mareike Rickmann, Laura Macke, Bala Sai Sundarasetty, Kathrin Stamer, Constanca Figueiredo, Rainer Blasczyk, Michael Heuser, Juergen Krauter, Arnold Ganser, Renata Stripecke
Homoharringtonine in combination with cytarabine and aclarubicin in the treatment of refractory/relapsed acute myeloid leukemia: a single-center experience
Wenjuan Yu, Liping Mao, Jiejing Qian, Wenbin Qian, Haitao Meng, Wenyuan Mai, Hongyan Tong, Yin Tong, Jie Jin
Escalated daunorubicin dosing as an induction treatment for Philadelphia-negative adult acute lymphoblastic leukemia
Sang Min Lee, Won Sik Lee, Ho Jin Shin, Je-Jung Lee, Sang Kyun Sohn, Joon Ho Moon, Hyeon Seok Eom, Jong Ho Won, Kyoo-Hyung Lee, Je-Hwan Lee, Dae-Young Kim, Sung-Soo Yoon, Inho Kim, Chul Won Jung, Seok Jin Kim, Hawk Kim, Jae Hoon Lee, Hun-Mo Ryoo, Gyeong-Won Lee, Sung-Hyun Kim, Yeung-Chul Mun, Min Kyoung Kim, Young Don Joo
Combined use of WT1 and flow cytometry monitoring can promote sensitivity of predicting relapse after allogeneic HSCT without affecting specificity
Xiao-su Zhao, Chen-hua Yan, Dai-hong Liu, Lan-ping Xu, Yan-rong Liu, Kai-yan Liu, Ya-zhen Qin, Yu Wang, Xiao-jun Huang
Ferritin concentrations correlate to outcome of hematopoietic stem cell transplantation but do not serve as biomarker of graft-versus-host disease
M. Großekatthöfer, E. D. Güclü, A. Lawitschka, S. Matthes-Martin, G. Mann, M. Minkov, C. Peters, M. G. Seidel
Double-hit myeloma with IGH/MYC and IGH/CCND1 translocations
Misuk Ji, Seongsoo Jang, Je-Hwan Lee, Eul-Ju Seo
Bevacizumab treatment followed by maintenance in life-threatening POEMS syndrome
Vittorio Perfetti, Giovanni Palladini, Mara De Amici, Luca Livraghi, Paolo Pedrazzoli, Giampaolo Merlini
Bortezomib induced a phrenic palsy in a multiple myeloma patient
Vitalie Nizeica, Philippe Collet, Hubert Marotte
Maintenance therapy with dasatinib after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia
Chieh-Lin Jerry Teng, Jui-Ting Yu, Hung-Chieh Chen, Wen-Li Hwang
Actinomycotic brain abscess as the first clinical manifestation of hereditary hemorrhagic telangiectasia—case report and review of the literature
M. Koubaa, D. Lahiani, I. Mâaloul, H. Fourati, L. Chaari, Ch. Marrakchi, Z. Mnif, Z. Boudawara, M. Ben Jemâa
Profound thrombocytopenia in patient with ITP treated with chemotherapy for breast cancer and subsequent remission after romiplostim
Ann Zimrin, Saranya Chumsri
A common founder mutation p.P2063S in exon 36 of VWF in 11 unrelated Indian von Willebrand disease (VWD) families
Priyanka Kasatkar, Kanjaksha Ghosh, Shrimati Shetty
Killing two birds with one stone: BRAF V600E inhibitor therapy for hairy cell leukemia and Langerhans/dendritic cell sarcoma
Vivek Subbiah, Ishwaria Mohan Subbiah